Enhanced external counterpulsation for the treatment of stable angina and heart failure: A systematic review and economic analysis

Health Technology Assessment

Volumn 13, Issue 24, 2009, Pages

  McKenna, C ^a   McDaid, C ^a   Suekarran, S ^a   Hawkins, N ^a   Claxton, K ^a   Light, K ^a   Chester, M ^a   Cleland, J ^a   Woolacott, N ^a   Sculpher, M ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; NITRIC ACID DERIVATIVE; PERINDOPRIL;

CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COUNTERPULSATION; DISEASE CLASSIFICATION; DRUG USE; ELECTRONIC MEDICAL RECORD; ENHANCED EXTERNAL COUNTERPULSATION; EXERCISE; HEALTH CARE COST; HEALTH ECONOMICS; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; META ANALYSIS; MORTALITY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REGISTER; REVASCULARIZATION; REVIEW; RISK FACTOR; SELF REPORT; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; SYSTEMATIC REVIEW; THEORETICAL MODEL; TREATMENT OUTCOME; ADULT; AGED; ANGINA PECTORIS; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; ANGINA PECTORIS; COUNTERPULSATION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 70449432798     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13240     Document Type: Review

References (138)

1. Blue Cross Blue Shield Association. External counterpulsation for treatment of chronic stable angina pectoris and chronic heart failure. TEC Assessment Program 2005;20(12):1-29.
2. O'Toole L. Angina (chronic stable). Clin Evid 2007. [Updated 1 April 2007; cited 24 October 2007.]
3. Abrams J. Chronic stable angina. N Engl J Med 2005;352:2424-2533
4. Allender S, Peto V, Scarborough P, Boxer A, Rayner M. Morbidity. In Coronary heart disease statistics. 15th edn. London: British Heart Foundation; 2007.
5. Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. The current cost of angina pectoris to the National Health Service in the UK. Heart 2003;89:848-853 (Pubitemid 36920803)
6. Scottish Intercollegiate Guidelines Network. Management of stable angina: a national clinical guideline. SIGN Guideline 96. Edinburgh: SIGN; 2007.
7. Henderson RA, Pocock SJ, Clayton T, Knight R, Fox KA, Julian DG, et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:1161-1170 (Pubitemid 37188334)
8. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliasson T, et al. The problem of chronic refractory angina: report from the ESC Joint Study Group on the treatment of refractory angina. Eur Heart J 2002;23:355-370 (Pubitemid 35204196)
9. Scottish Intercollegiate Guidelines Network. Management of chronic heart failure: a national clinical guideline. SIGN Guideline 95. Edinburgh: SIGN; 2007.
10. McKelvie R. Heart failure. Clin Evid 2007. Published online 1 January 2007.
11. Cowie MR, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Suresh V, et al. Incidence and aetiology of heart failure. Eur Heart J 1999;20:421-428
12. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 2002;23:1867-1876 (Pubitemid 35398056)
13. Sinvhal RM, Gowda RM, Khan IA. Enhanced external counterpulsation for refractory angina pectoris. Heart 2003;89:830-833 (Pubitemid 36920798)
14. Ontario Ministry of Health and Long-Term Care. Enhanced external counterpulsation (EECP): health technology policy assessment update March 2006. Toronto: Medical Advisory Secretariat, Ontario Ministry of Health and Long-term Care (MAS); 2006.
15. Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews [CRD Report 4]. 2nd edn. York: Centre for Reviews and Dissemination; 2001.
16. Deeks J, Dinnes J, D'Amico R, Sowden A, Sakarovitch C, Song F. Evaluating non-randomised intervention studies. Health Technol Assess 2003;7(27).
17. Arora R, Chou T, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999;33:1833-1840
18. Barsheshet A, Hod H, Shechter M, Sharabani-Yosef O, Rosenthal E, Barbash IM, et al. The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris. Cardiology 2008;110:160-166 (Pubitemid 351799052)
19. Holubkov R, Kennard E, Foris J, Kelsey S, Soran O, Williams D, et al. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. Am J Cardiol 2002;89:1182-1186 (Pubitemid 34468065)
20. Shechter M, Matetzky S, Feinberg M, Chouraqui P, Rotstein Z, Hod H. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol 2003;42:2090-2095 (Pubitemid 37549890)
21. Feldman AM, Silver MA, Francis GS, Abbottsmith CW, Fleishman BL, Soran O, et al. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1198-1205 (Pubitemid 44345118)
22. Arora R, Chou T, Jain D, Fleishman B, Crawford L, McKiernan T, et al. Effects of enhanced external counterpulsation on health-related quality of life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. J Investig Med 2002;50:25-32. (Pubitemid 34098285)
23. Drummond M, Jefferson T. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275-283 (Pubitemid 26254740)
24. Aequitas Consulting Group. Enhanced external counterpulsation for the treatment of patients with chronic sable angina pectoris: a cost-utility analysis [industry submission]. San Diego, CA: Aequitas Consulting Group; 2004.
25. Michaels A, Linnemeier G, Soran O, Kelsey S, Kennard E. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry). Am J Cardiol 2004;93:461-464 (Pubitemid 38221358)
26. Kandzari DE, Lam LC, Eisenstein EL, Clapp-Channing N, Fine JT, Califf RM, et al. Advanced coronary artery disease: appropriate endpoints for trials of novel therapies. Am Heart J 2001;142:843-851 (Pubitemid 33016204)
27. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-468
28. National Institute for Clinical Excellence. Guidance to the methods of technology appraisal. London: NICE; 2004.
29. Doubilet P, Begg C, Weinstein M. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 1985;5:155-177 (Pubitemid 16130640)
30. Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 2002;22:290-308. (Pubitemid 34791317)
31. The R Foundation for Statistical Computing. The R project for statistical computing. 2008. URL: www.r-project.org/.
32. Claxton K, Ginnelly L, Sculpher MJ, Philips Z, Palmer S. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess 2004;8:(31).
33. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996;5:513-524
34. Ware JE, Kosinski M, Keller SD. The SF-36 physical and mental summary scales: a user's manual. Boston, MA: The Health Institute; 1994.
35. Ara R, Brazier J. Deriving an algorithm to convert the 8 mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health 2008;11(7):1131-1143 Published online 2008.
36. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. Centre for Health Economics Discussion Paper 172. York: Centre for Health Economics, University of York; 1999.
37. Soran O, Kennard E, Kfoury A, Kelsey S. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (from The International EECP Patient Registry). Am J Cardiol 2006;97:17-20. (Pubitemid 41828115)
38. Loh PH, Cleland JGF, Louis AA, Kennard ED, Cook JF, Caplin JL, et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the international enhanced external counterpulsation patient registry. Clin Cardiol 2008;31:159-164
39. O'Hagan A, Buck CE, Daneshkhah A, Eiser JR, Garthwaite PH, Jenkinson DJ, et al. Uncertain judgements. Eliciting experts' probabilities. Chichester: Wiley; 2006.
40. van Noortwijk JM, Dekker A, Cooke RM, Mazzuchi TA. Expert judgment in maintenance optimization. IEEE Transactions on Reliability 1992;41:427-432
41. Cooke RM. Experts in uncertainty: opinion and subjective probability in science. New York: Oxford University Press; 1991.
42. Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, et al. Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 2007;93:1081-1086 (Pubitemid 47310987)
43. Anderson KM, Odell PM, Wilson PW. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-298
44. Government Actuary's Department. Interim life tables. Office for National Statistics; 2007. URL: www.gad.gov.uk/Demography%5FData/Life-Tables/Interim- life-tables.asp.
45. Michaels A, Barsness G, Soran O, Kelsey S, Kennard E, Hui J, et al. Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry). Am J Cardiol 2005;95:394-397 (Pubitemid 40164547)
46. Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
47. Johannesson M, Weinstein S. On the decision rules of cost-effectiveness analysis. J Health Econ 1993;12:459-467
48. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-789 (Pubitemid 34041389)
49. Devlin N, Parkin D. Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 2004;13:437-452 (Pubitemid 38660393)
50. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research - some lessons from recent UK experience. Pharmacoeconomics 2006;24:1055-1068
51. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-364 (Pubitemid 29242816)
52. Allender S, Peto V, Scarborough P, Boxer A, Rayner M. Coronary heart disease statistics. British Heart Foundation Statistics Database; 2007. URL: www.heartstats.org.
53. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modelling. Med Decis Making 2004;24:207-226 (Pubitemid 38391940)
54. Conti S, Claxton K. Dimensions of design space: a decision-theoretic approach to optimal research design. Centre for Health Economics Discussion Paper 38. York: Centre for Health Economics, University of York; 2008.
55. Boden WE, O'Rourke R, Teo KK, Hartigan PM, Maron DJ, Kostuk W, et al. The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial. Am J Cardiol 2007;99:208-212 (Pubitemid 46072756)
56. Lapenna E, Rapati D, Cardano P, De Bonis M, Lullo F, Zangrillo A, et al. Spinal cord stimulation for patients with refractory angina and previous coronary surgery. Ann Thorac Surg 2006;82:1704-1708 (Pubitemid 44740013)
57. Yang EH, Barsness GW, Gersh BJ, Chandrasekaran K, Lerman A. Current and future treatment strategies for refractory angina. Mayo Clin Proc 2004;79:1284-1292 (Pubitemid 39299074)
58. Kind P. The EuroQoL instrument: an index of health-related quality of life. In Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Philadelphia: Lippincott-Raven; 1996.
59. Akhtar M, Wu G-F, Du Z-M, Zheng Z-S, Michaels AD. Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels. Am J Cardiol 2006;98:28-30. (Pubitemid 43902681)
60. Arora RR, Carlucci ML, Malone AM, Baron NV. Acute and chronic hemodynamic effects of enhanced external counterpulsation in patients with angina pectoris. J Investig Med 2001;49:500-504 (Pubitemid 33104583)
61. Arora RR, Lopez S, Saric M. Enhanced external counterpulsation improves systolic function by echocardiography in patients with coronary artery disease. Heart Lung 2005;34:122-125 (Pubitemid 40343088)
62. Bagger P. Enhanced external counterpulsation treatment of patients with chronic heart failure. National Research Register 2007; Issue 4.
63. Bagger J, Hall RC, Koutroulis G, Nihoyannopoulos P. Effect of enhanced external counterpulsation on dobutamine-induced left ventricular wall motion abnormalities in severe chronic angina pectoris. Am J Cardiol 2004;93:465-467 (Pubitemid 38221359)
64. Barsness G, Feldman A, Holmes D, Holubkov R, Kelsey S, Kennard E, et al. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol 2001;24:435-442 (Pubitemid 32520213)
65. Bonetti P, Barsness G, Keelan P, Schnell T, Pumper G, Kuvin J, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003;41:1761-1768 (Pubitemid 36584250)
66. Cleland JGF. Enhanced external counter-pulsation for angina. National Research Register 2007; Issue 4.
67. Cohn PF, Lawson WE. Role of enhanced external counterpulsation in angina treatment. J Myocard Ischemia 1994;6:25-27
68. Cohn PF, Lawson WE, Burger L, Hui JCK. Enhanced external counterpulsation: a new therapeutic option for patients who have failed coronary angioplasty and/or bypass surgery. Cardiovasc Rev Rep 1997;18:10-21. (Pubitemid 27213086)
69. Dockery F, Rajkumar C, Bulpitt CJ, Hall RJ, Bagger JP. Enhanced external counterpulsation does not alter arterial stiffness in patients with angina. Clin Cardiol 2004;27:689-692 (Pubitemid 39610505)
70. El-Sakka AI, Morsy AM, Fagih BI. Enhanced external counterpulsation in patients with coronary artery disease-associated erectile dysfunction. Part II: impact of disease duration and treatment courses. J Sex Med 2007;4:1448-1453 (Pubitemid 47337693)
71. El-Sakka A, Morsy A, Fagih B. Enhanced external counterpulsation in patients with coronary artery disease-associated erectile dysfunction. Part I: effects of risk factors. J Sex Med 2007;4:771-779 (Pubitemid 46779314)
72. Fitzgerald C, Lawson W, Hui J, Kennard E. Enhanced external counterpulsation as initial revascularization treatment for angina refractory to medical therapy. Cardiology 2003;100:129-135 (Pubitemid 37465142)
73. Fricchione GL, Jaghab K, Lawson W, Hui JCK, Jandorf L, Zheng ZS, et al. Psychosocial effects of enhanced external counterpulsation in the angina patient. Psychosomatics 1995;36:494-497
74. Gloth S, Oken HA. Enhanced external counter pulsation: the Howard County experience in the first 18 patients. Md Med J 1999;48:155-156
75. Guo XB, Guo HS, Wang XP, Chen SW, Wei JR, Huang LP. Enhanced external counterpulsation and exercise tolerance and plasm endothelial function in patients with coronary heart disease. Chin J Clin Rehabil 2005;9:38-39 (Pubitemid 41574999)
76. Hall RJC. Enhanced external counterpulsation treatment of patients with refractory angina pectoris. National Research Register 2007; Issue 4.
77. Henrikson CA, Chandra-Strobos N. Enhanced external counterpulsation therapy: significant clinical improvement without electrophysiologic remodeling. Ann Noninvasive Electrocardiol 2004;9:265-269 (Pubitemid 39044079)
78. Kaluski E, Gabara Z, Uriel N, Milo O, Leitman M, Weisfogel J, et al. The benefits and safety of external counterpulsation in symptomatic heart failure. IMAJ 2006;8:687-690 (Pubitemid 44696905)
79. Kasliwal RR, Mittal S, Kanojia A, Bhatia ML, Kronzon I, Trehan N. Sequential external counterpulsation: an adjunctive therapy for patients with chronic coronary artery disease and left ventricular dysfunction. Indian Heart J 1996;48:150-154 (Pubitemid 126504305)
80. Lakshmi MV, Kennard ED, Kelsey SF, Holubkov R, Michaels AD. Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry). Am J Cardiol 2002;89:1303-1305 (Pubitemid 34606895)
81. Lawson WE, Hui JCK, Kennard ED, Soran O, McCullough PA, Kelsey SF. Effect of enhanced external counterpulsation on medically refractory angina patients with erectile dysfunction. Int J Clin Pract 2007;61:757-762 (Pubitemid 46587874)
82. Lawson W, Hui J, Barsness G, Kennard E, Kelsey S. Effectiveness of enhanced external counterpulsation in patients with left main disease and angina. Clin Cardiol 2004;27:459-463 (Pubitemid 38998806)
83. Lawson W, Hui J, Lang G. Treatment benefit in the Enhanced External Counterpulsation Consortium. Cardiology 2000;94:31-35
84. Lawson WE, Hui JC, Guo T, Burger L, Cohn PF. Prior revascularization increases the effectiveness of enhanced external counterpulsation. Clin Cardiol 1998;21:841-844 (Pubitemid 28535747)
85. Lawson W, Silver M, Hui J, Kennard E, Kelsey S. Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation. J Card Fail 2005;11:61-66 (Pubitemid 40215316)
86. Lawson WE, Hui JCK, Kennard ED, Kelsey SF, Michaels AD, Soran O. Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation. Clin Cardiol 2006;29:69-73. (Pubitemid 43235184)
87. Lawson WE, Barsness G, Michaels AD, Soran O, Kennard ED, Kelsey SF, et al. Effectiveness of repeat enhanced external counterpulsation for refractory angina in patients failing to complete an initial course of therapy. Cardiology 2007;108:170-175 (Pubitemid 47525214)
88. Lawson W, Hui J, Cohn P. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol 2000;23:254-258 (Pubitemid 30183389)
89. Lawson WE, Hui JCK, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, et al. Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992;70:859-862
90. Lawson WE, Hui JCK, Zheng ZS, Burgen L, Jiang L, Lillis O, et al. Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology 1996;87:271-275 (Pubitemid 26168118)
91. Lawson WE, Hui JCK, Zheng ZS, Burger L, Jiang L, Lillis O, et al. Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am J Cardiol 1996;77:1107-1109 (Pubitemid 26183729)
92. Lawson WE, Hui JCK, Zheng ZS, Oster Z, Katz JP, Diggs P, et al. Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995;75:840-841
93. Lawson WE, Kennard ED, Holubkov R, Kelsey SF, Strobeck JE, Soran O, et al. Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure. Cardiology 2001;96:78-84. (Pubitemid 33153175)
94. Lawson W, Kennard E, Hui J, Holubkov R, Kelsey S. Analysis of baseline factors associated with reduction in chest pain in patients with angina pectoris treated by enhanced external counterpulsation. Am J Cardiol 2003;92:493-503
95. Lawson W, Hui J, Kennard E, Barsness G, Kelsey S. Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders. Cardiology 2005;103:201-206 (Pubitemid 40875053)
96. Lee C-M, Wu Y-W, Jui H-Y, Chen M-F, Lee Y-T, Soran O. Enhanced external counterpulsation reduces lung/heart ratio at stress in patients with coronary artery disease. Cardiology 2006;106:237-240 (Pubitemid 44763177)
97. Levenson J, Simon A, Megnien JL, Chironi G, Gariepy J, Pernollet MG, et al. Effects of enhanced external counterpulsation on carotid circulation in patients with coronary artery disease. Cardiology 2007;108:104-110 (Pubitemid 47295569)
98. Linnemeier G, Rutter M, Barsness G, Kennard E, Nesto R. Enhanced external counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes. Am Heart J 2003;146:453-458 (Pubitemid 37083078)
99. Linnemeier G, Michaels AD, Soran O, Kennard ED. Enhanced external counterpulsation in the management of angina in the elderly. Am J Geriatr Cardiol 2003;12:90-96
100. Loh PH. Enhanced external counterpulsation (EECP) in patients with ischaemic heart disease and chronic left ventricular systolic dysfunction evaluation. National Research Register 2007; Issue 4.
101. Loh PH, Louis AA, Windram J, Rigby AS, Cook J, Hurren S, et al. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina. J Intern Med 2006;259:276-284
102. Masuda D, Fujita M, Nohara R, Matsumori A, Sasayama S. Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina. Heart Vessels 2004;19:59-62. (Pubitemid 38489031)
103. Masuda D, Nohara R, Hirai T, Kataoka K, Chen LG, Hosokawa R, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina: evaluation by (13)N-ammonia positron emission tomography. Eur Heart J 2001;22:1451-1458 (Pubitemid 32769172)
104. McCullough PA, Henry TD, Kennard ED, Kelsey SF, Michaels AD. Residual high-grade angina after enhanced external counterpulsation therapy. Cardiovasc Revasc Med 2007;8:161-165 (Pubitemid 47332354)
105. McCullough PA, Silver MA, Kennard ED, Kelsey SF, Michaels AD. Impact of body mass index on outcomes of enhanced external counterpulsation therapy. Am Heart J 2006;151:139.e9-39.e13.
106. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002;106:1237-1242 (Pubitemid 34988642)
107. Michaels AD, Kennard ED, Kelsey SE, Holubkov R, Soran O, Spence S, et al. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation? Data from the International EECP Patient Registry (IEPR). Clin Cardiol 2001;24:453-458 (Pubitemid 32520215)
108. Michaels AD, McCullough PA, Soran OZ, Lawson WE, Barsness GW, Henry TD, et al. Primer: practical approach to the selection of patients for and application of EECP. Nat Clin Pract Cardiovasc Med 2006;3:623-632
109. Michaels AD, Raisinghani A, Soran O, de Lame P-A, Lemaire ML, Kligfield P, et al. The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study. Am Heart J 2005;150:1066-1073 (Pubitemid 41613721)
110. Michaels AD, Raisinghani A, Soran O, de Lame P-A, Lemaire ML, Watson DD, et al. The effects of enhanced counterpulsation on myocardial perfusion in patients with stable angina: a single blind multicentre pilot study. J Am Coll Cardiol 2004;3(45 Suppl. A):308A(891-4).
111. Moore R. A randomised control trial in the treatment of refractory angina with enhanced computerisation (EECP). National Research Register 2007; Issue 4.
112. Nichols WW, Estrada JC, Braith RW, Owens K, Conti CR. Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol 2006;48:1208-1214 (Pubitemid 44345138)
113. Novo G, Bagger JP, Carta R, Koutroulis G, Hall R, Nihoyannopoulos P. Enhanced external counterpulsation for treatment of refractory angina pectoris. J Cardiovasc Med 2006;7:335-339 (Pubitemid 44145636)
114. Ochoa AB, deJong A, Grayson D, Franklin B, McCullough P. Effect of enhanced external counterpulsation on resting oxygen uptake in patients having previous coronary revascularization and in healthy volunteers. Am J Cardiol 2006;98:613-615
115. Olsson H. Quality of competence in the role of nursing - as result of education, professional practice and research. Vard Nord Utveckl Forsk 1999;19:5-10.
116. Pettersson T, Bondesson S, Cojocaru D, Ohlsson O, Wackenfors A, Edvinsson L. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation. BMC Cardiovasc Disord 2006;6:28. (Pubitemid 44123462)
117. Rana JS, Mannam A, Donnell-Fink L, Gervino EV, Sellke FW, Laham RJ. Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am J Cardiol 2005;95:1456-1459 (Pubitemid 40824767)
118. Sajja V, Dod H, Beto R, Jain AC, Hobbs GR, Finkel MS. An analysis of the efficacy and safety of enhanced external counterpulsation at West Virginia University Hospitals. W V Med J 2007;103:10-12.
119. Soran O, Fleishman B, Demarco T, Grossman W, Schneider VM, Manzo K, et al. Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 2002;8:204-8, 27.
120. Soran O, Kennard ED, Bart BA, Kelsey SF. Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction. Congest Heart Fail 2007;13:36-40.
121. Soran O, Kennard E, Kelsey S, Holubkov R, Strobeck J, Feldman A. Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR). Congest Heart Fail 2002;8:297-302.
122. Springer S, Fife A, Lawson W, Hui JCK, Jandorf L, Cohn PF, et al. Psychosocial effects of enhanced external counterpulsation in the angina patient: a second study. Psychosomatics 2001;42:124-132 (Pubitemid 32180000)
123. Stys TP, Lawson WE, Hui JCK, Fleishman B, Manzo K, Strobeck JE, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002;89:822-824 (Pubitemid 34241459)
124. Stys T, Lawson WE, Hui JCK, Lang G, Liuzzo J, Cohn PF. Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology 2001;52:653-658 (Pubitemid 32963568)
125. Sun J. Hemodynamic study of external counterpulsation with left and right cardiac catheters in 15 cases. Chung Hua Hsin Hsueh Kuan Ping Tsa Chih 1991;19:375-8, 98.
126. Tartaglia J, Stenerson J, Charney R, Ramasamy S, Fleishman B, Gerardi P, et al. Exercise capability and myocardial perfusion in chronic angina patients treated with enhanced external counterpulsation. Clin Cardiol 2003;26:287-290 (Pubitemid 36667536)
127. Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001;37:93-99 (Pubitemid 32051724)
128. Vijayaraghavan K, Santora L, Kahn J, Abbott N, Torelli J, Vardi G. New graduated pressure regimen for external counterpulsation reduces mortality and improves outcomes in congestive heart failure: a report from the Cardiomedics External Counterpulsation Patient Registry. Congest Heart Fail 2005;11:147-152
129. Walker S. Is a high diastolic augmentation ratio achieved during EECT therapy, a good indicator for patient benefit. National Research Register 2007;Issue 4.
130. Weisfogel G, Schaffer M, Gann D, Dadourian B, Marshall T, Allymadian V. External counterpulsation produces a significant reduction in stable angina class, episodes, medication use, and hospitalization. Cardiovasc Rev Rep 2001;22:154-158 (Pubitemid 32216155)
131. Werner D, Kropp J, Schellong S, Friedel C, Voigt J-U, Ludwig J, et al. Practicability and limitations of enhanced external counterpulsation as an additional treatment for angina. Clin Cardiol 2003;26:525-529 (Pubitemid 37346090)
132. Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J Afr 2007;18:154-156 (Pubitemid 47345204)
133. Yi Y, Yang Y, Jian C. Cerebral hemodynamic impairment and therapeutic effect of external counterpulsation on elderly patients with brain infarction. Bull Hunan Med Univ 1999;24:435-437
134. Youcheng S. External counterpulsation in treating angina pectoris evaluated by TI-201 myocardial perfusion imaging. Chung Hua Hsin Hsueh Kuan Ping Tsa Chih 1991;19:235-7, 68.
135. Zheng ZS. Clinical observations on 142 cases of angina pectoris treated by four-limb sequenced external counterpulsation. Chung Hua I Hsueh Tsa Chih 1981;61:415-417
136. Zheng Z-S, Li T-M, Kambic H, Chen G-H, Yu L-Q, Cai S-R, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983;29:599-603. (Pubitemid 14537171)
137. Abbottsmith CW, Chung ES, Varricchione T, de Lame P-A, Silver MA, Francis GS, et al. Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail 2006;12:307-311
138. Feldman A, Silver M, Francis G, De Lame P, Parmley W. Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. J Card Fail 2005;11:240-245 (Pubitemid 40462429)